Using PBS and MBS data to report on the treatment and management of chronic respiratory conditions 2016–17
Citation
AIHW
Australian Institute of Health and Welfare (2018) Using PBS and MBS data to report on the treatment and management of chronic respiratory conditions 2016–17, AIHW, Australian Government, accessed 28 March 2024.
APA
Australian Institute of Health and Welfare. (2018). Using PBS and MBS data to report on the treatment and management of chronic respiratory conditions 2016–17. Canberra: AIHW.
MLA
Australian Institute of Health and Welfare. Using PBS and MBS data to report on the treatment and management of chronic respiratory conditions 2016–17. AIHW, 2018.
Vancouver
Australian Institute of Health and Welfare. Using PBS and MBS data to report on the treatment and management of chronic respiratory conditions 2016–17. Canberra: AIHW; 2018.
Harvard
Australian Institute of Health and Welfare 2018, Using PBS and MBS data to report on the treatment and management of chronic respiratory conditions 2016–17, AIHW, Canberra.
PDF | 711Kb
This report investigates the utility of the Pharmaceuticals Benefits Scheme (PBS) and Medicare Benefits Schedule (MBS) claims data in answering key research questions for reporting on the treatment and management of chronic respiratory conditions in Australia. It also includes high level analysis on medications dispensed for the treatment and management of chronic respiratory conditions in 2016–17, and dispensing patterns.
- ISBN: 978-1-76054-456-0
- Cat. no: ACM 37
- Pages: 60
-
15 key questions were identified important for monitoring chronic respiratory conditions
-
PBS data can answer 10 out of 15 questions: medication type; dispensing patterns; costs; uptake of new medications
-
PBS-MBS data cannot answer 5 out of 15 questions: adherence to treatment; reason for the prescription of medications
-
In 2016–17, over 16.5 million prescriptions were dispensed to more than 3.5 million individuals